Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
How has the mesenchymal stem cells market grown over the years?
In the last few years, the market size for mesenchymal stem cells has seen a significant expansion. It is projected to increase from a value of $3.38 billion in 2024 to $3.82 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 13.0%. Such growth over the historical period is largely due to a shift towards regenerative medicine, joint research initiatives, heightened public understanding and support for stem cell research, collaborations on an international level, and efforts to standardize practices.
What Is the forecasted market size and growth rate for the mesenchymal stem cells market?
The market size for mesenchymal stem cells is anticipated to experience significant expansion in the upcoming years, reaching a value of $6.14 billion by the year 2029, with a compound annual growth rate (CAGR) of 12.6%. This expected growth over the forecast period can be linked with ongoing progress in genetic engineering technologies, the embracement of personalized therapy methods, the incorporation of artificial intelligence (AI) and data analytics, improvements in the field of biomaterials science and 3D bioprinting technologies, the creation of microfluidic devices and organ-on-a-chip models, and the use of next-generation production technologies. Over the forecast period, notable trends will include bioprinting, tissue engineering, gene editing and expansion of clinical applications, combination therapies, and mesenchymal stem cell-derived extracellular vesicles (EVs).
Get your mesenchymal stem cells market report here!
https://www.thebusinessresearchcompany.com/report/mesenchymal-stem-cells-global-market-report
What are the major factors driving growth in the mesenchymal stem cells market?
The rise in understanding and awareness about regenerative medicine is predicted to stimulate the expansion of the mesenchymal stem cells (MSC) market in the future. Regenerative medicine is a newly evolving interdisciplinary domain that aims to mend, replace, or regenerate cells, tissues, or organs to reinstate compromised function induced by any source, encompassing congenital defects, disease, trauma, and aging. The escalation in regenerative medicine is due to numerous indispensable reasons, like the increasing number of clinical trials, the surge in chronic and age-related diseases, and personalized medicine. Mesenchymal stem cells (MSCs) provide considerable potential in regenerative medicine with their exceptional capability to transform into various cell types, control immune reactions, and aid in tissue restoration and regeneration across a broad range of health conditions. For example, as stated in a report by the Alliance for Regenerative Medicine, a US-based non-profit entity, in August 2023, there was an increase of 101% in cell, gene, and tissue-engineering therapeutic developers across the globe to 2,760 in Q1 2023 from 1,369 in Q1 2022. Moreover, according to a report released by the American Society of Gene & Cell Therapy (ASGCT), a professional US-based membership organization, and Citeline, a US-based drug and device provider, in July 2023, although there were 247 gene therapies in Phase II at Q1 2023 end, a 5% increase was witnessed which took the number to 260 by Q2 end. Hence, the ascending awareness about regenerative medicine is catalyzing the growth of the mesenchymal stem cell (MSC) market.
What key areas define the segmentation of the global mesenchymal stem cells Market?
The mesenchymal stem cells market covered in this report is segmented –
1) By Type: Autologous, Allogeneic
2) By Product Type: Cells And Cell Lines, Kits, Media And Reagents, Other Product Types
3) By Workflow Type: Cell Sourcing And Isolation, Culture And Cryopreservation, Differentiation, Characterization
4) By Indication: Bone And Cartilage Repair, Cardiovascular Diseases, Inflammatory And Immunological Diseases, Liver Diseases, Cancer, GvHD, Other Indications
5) By Application: Disease Modeling, Drug Development And Discovery, Stem Cell Banking, Tissue Engineering, Toxicology Studies, Other Applications
Subsegments:
1) By Autologous: Bone Marrow-Derived, Adipose Tissue-Derived, Cord Blood-Derived, Peripheral Blood-Derived
2) By Allogeneic: Bone Marrow-Derived, Umbilical Cord-Derived, Placental-Derived, Induced Pluripotent Stem Cells (iPSCs) Derived, Wharton’s Jelly-Derived
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16116&type=smp
What are the top market players propelling the growth of the mesenchymal stem cells industry?
Major companies operating in the mesenchymal stem cells market are Thermo Fischer Scientific Inc., Danaher Corporation, Merck KgaA, Becton, Dickinson, and Company, Fujifilm Holdings Corporation, Corning Inc., Daiichi Sankyo, Lonza Group, Terumo Corporation, Sartorius AG, Getinge AB, Bio-Rad Laboratories, Eppendorf AG, Bio-Techne Corporation, STEMCELL Technologies Inc., Miltenyi Biotec GmBH, Takara Bio Group, Organogenesis Holdings Inc., Vericel Corporation, HiMedia Laboratories, PromoCell GmbH, CellGenix GmBH, Anterogen Co. Ltd., Pluristem Therapeutics Inc., American Cryostem Corporation
What are the key trends shaping the future of the mesenchymal stem cells market?
Leading enterprises in the mesenchymal stem cells (MSCs) market are integrating innovative techniques like GMP-compliant isolation to solidify their market standing. This refers to the extraction of cells, including MSCs, in line with GMP regulations to guarantee consistent product creation and quality control. For example, PromoCell, a German biotech firm, in July 2023, unveiled the PromoExQ MSC Growth Medium XF. This serum and xeno-free medium is specially devised for the growth of human mesenchymal stem cells (MSCs) in a Good Manufacturing Practice (GMP) compliant setting. This medium is fabricated following the stringent quality standards and certified by the EXCiPACT GMP certification scheme, ensuring steady growth and care of MSCs from various origins like bone marrow, umbilical cord matrix, and adipose tissue.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16116
What regions are dominating the mesenchymal stem cells market growth?
North America was the largest region in the mesenchymal stem cells market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mesenchymal stem cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Stem Cell Therapy Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report
Induced Pluripotent Stem Cell (iPSC) Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/induced-pluripotent-stem-cell-global-market-report
Stem Cell/Cord Blood Banking Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/stem-cell-cord-blood-banking-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
